This can be illustrated by testing clinical isolates with varying persister frequencies in tube assays versus cell-based models
Hematocrit, reticulocyte count, vitamin B12, folate and iron levels should be obtained prior to treatment
Additional Research Notes Improper storage, reconstitution, or handling practices may increase the likelihood of: Injection-site irritation Local sensitivity reactions Reduced peptide stability or consistency Response variability between research protocols Responses and tolerability observations may vary depending on: Dosage range Administration frequency Protocol duration Skin type and physiological status Overall individual sensitivity For Research Use Only Not intended to diagnose, treat, cure, or prevent any disease
Novinscak T, et al
Others use a week-based system, using the right side on odd days and left side on even days
Potential concerns include: Unknown product quality Contamination or sterility issues Incorrect dosing Injection site reactions Allergic or immune reactions Medication interactions Hormonal or metabolic effects Unclear long-term safety Lack of monitoring Delayed treatment for an actual injury or medical condition Medical oversight is especially important for patients with autoimmune conditions, cancer history, active infections, chronic inflammatory disorders, cardiovascular concerns, hormone-sensitive conditions, or complex medication regimens
